Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecular Imaging-Based Cryoneurolysis in Chronic Pain
NCT07768501Phase 1Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Sep 2029
01
Overview
Phase 1, open-label, single-arm trial of [18F]-FTC-146 in chronic pain. Primary endpoint: Pain Disability Index at 12 months. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
[18F]-FTC-146
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT07768501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07768501.